B
1.81
-0.19 (-9.50%)
| Penutupan Terdahulu | 2.00 |
| Jumlah Dagangan | 10,872 |
| Harga / Jualan (P/S) | 0.330 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -610.00% |
| EPS Cair (TTM) | -1.22 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 101.28% |
| Nisbah Semasa (MRQ) | 2.35 |
| Aliran Tunai Operasi (OCF TTM) | -57.40 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -34.48 M |
| Pulangan Atas Aset (ROA TTM) | -65.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -246.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | BioAtla, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Nilai 35% | -1.5 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -1.5 |
| Masa 35% | 2.2 |
| AI Technical info | NA |
| Osilator Teknikal info | 2.0 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×0.79 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -17.9% |
| Persetujuan Tonggak | ×0.84 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -0.3 |
| Skor Akhir | 0.16 |
|
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.66% |
| % Dimiliki oleh Institusi | 32.52% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |